Ozempic for All?

奥泽米普——全民之选?

The Daily

2025-11-14

22 分钟
PDF

单集简介 ...

Drugs like Ozempic and Zepbound have revolutionized weight loss. And starting next year, the drugs are going to become more affordable for Americans because of a deal struck with pharmaceutical companies by the Trump administration. Eshe Nelson, who covers economics and business news, explains how the change has its origins in a huge business blunder from the creator of Ozempic, Novo Nordisk. Guest: Eshe Nelson, a reporter for The New York Times based in London, where she covers economics and business news. Background reading:  How Ozempic’s maker lost its shine after creating a wonder drug.What Trump’s new drug pricing deal means for people with obesity.Photo: Sergei Gapon/Agence France-Presse — Getty Images For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.  Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
更多

单集文稿 ...

  • How is internet culture shaping coming-of-age rituals around the world?

  • And how I would get ready with me videos reaching a new audience.

  • Hi there, I'm Isabella Rossellini.

  • In the latest episode of This is Not a Beauty podcast from L'Oreal Group,

  • we learn about how beauty is shaping the internet from a London-based text journalist and a Mexican teenager preparing for her quinceanera.

  • Listen now on your favorite podcast platform.

  • From the New York Times, I'm Natalie Ketrowef.

  • This is the Daily.

  • In the coming year,

  • GLP won drugs like Osempic and Monjaro may become way more attainable for millions of Americans,

  • as President Trump promises to lower their costs and drug makers race to release them in pill form,

  • paving the way for what could be the next revolution in weight loss.

  • Today, my colleague Isha Nelson, on how that story of accessibility actually started years ago,

  • when one company invented the first version of these drugs and then lost control of them.

  • It's Friday, November 14th.

  • Isha, you've been covering Ozempic and this new class of weight loss drugs.

  • And we're coming to you because it seems as

  • though we may be approaching a real turning point in our collective relationship to these medications.

  • So just tell me about how you're thinking about this moment.

  • Yes,